NCT02997228 2026-03-18Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyNational Cancer Institute (NCI)Phase 3 Active not recruiting120 enrolled